🔎 Trials Near Me

Gara Jalqabaatti › Dhukkubaa Alzheimer › Florida › Orlando

Qorannoo klinikaalii Dhukkubaa Alzheimer Orlando, FL keessatti

Qorannoo 25 Dhukkubaa Alzheimer f Orlando fi naannoo isaa (kilomeetira 30 keessatti) hirmaatuu jiru. Qorannoo banaa eenyu akka hirmaatu fi akkamitti garee qorannoo akka quunnaman ilaali.

Takkalaa qorannoo (Ingiliffa)

Qorannoo hirmaatuu barbaadduu? Fuula kana jalatti agarsiisi — $99 guyyaa 30f →

A Study to Assess the Efficacy and Safety of ML-007C-MA for the Treatment of Alzheimer's Disease Psychosis

Namoota walitti qabaa jiraSadarkaa 2
  • Clinical Site, Orlando
Umuriin 55 hanga 90 · Saalaa hunda · Haaromfame 30-Ful-2026 · NCT06887192

A Study to Assess the Efficacy and Safety of ITI-1284 in the Treatment of Psychosis Associated With Alzheimer's Disease

Namoota walitti qabaa jiraSadarkaa 2
  • K2 Medical Research, Maitland · Miili 6 fagaatti
Umuriin 55 fi ol · Saalaa hunda · Haaromfame 29-Ful-2026 · NCT06540833

A Study to Evaluate the Long-term Efficacy and Safety of KarXT + KarX-EC for Agitation in Alzheimer's Disease (ADAGIO-3)

Namoota walitti qabaa jiraSadarkaa 3
  • Local Institution - 1635, Orlando
Umuriin 55 hanga 90 · Saalaa hunda · Haaromfame 28-Ful-2026 · NCT06937229

A Study of LY3439539 in Participants With Alzheimer's Disease

Namoota walitti qabaa jiraSadarkaa 1
  • Charter Research, Orlando
  • AdventHealth Orlando, Orlando
  • K2 Medical Research, Maitland · Miili 6 fagaatti
Umuriin 50 hanga 85 · Saalaa hunda · Haaromfame 24-Ful-2026 · NCT07598370

A Study to Evaluate KarXT as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-4)

Namoota walitti qabaa jiraSadarkaa 3
  • Charter Research Orlando, Orlando
  • Nova Psychiatry, Orlando
  • Combined Research Orlando Phase I-IV LLC, Orlando
  • fi 1 dabalataa
Umuriin 55 hanga 90 · Saalaa hunda · Haaromfame 22-Ful-2026 · NCT06585787

A Study of Donanemab (LY3002813) in Participants With Early Cognitive Decline (TRAILBLAZER-ALZ 7)

Namoota walitti qabaa jiraSadarkaa 2
  • Charter Research - Orlando, Orlando
  • Conquest Research, Winter Park · Miili 5 fagaatti
  • K2 Medical Research ORLANDO, Maitland · Miili 6 fagaatti
Umuriin 55 hanga 85 · Saalaa hunda · Haaromfame 22-Ful-2026 · NCT07589595

Study of LHP588 in Subjects With P. Gingivalis-Positive Alzheimer's Disease

Namoota walitti qabaa jiraSadarkaa 2
  • Conquest Research - Lake Nona, Orlando
Umuriin 55 hanga 80 · Saalaa hunda · Haaromfame 21-Ful-2026 · NCT06847321

Screening Study to Determine Individuals With Potential Trial Eligibility for Alzheimer's Disease Studies

Namoota walitti qabaa jiraSadarkaa 3
  • Charter Research - Winter Park/Orlando, Orlando
  • Conquest Research - Lake Nona, Orlando
  • Conquest Research, LLC, Winter Park · Miili 5 fagaatti
  • fi 2 dabalataa
Umuriin 50 hanga 90 · Saalaa hunda · Haaromfame 21-Ful-2026 · NCT07177352

A Study to Assess the Safety and Effects of ABBV-1758 Following Subcutaneous or Intravenous Injections in Participants With Alzheimer's Disease

Namoota walitti qabaa jiraSadarkaa 1/2
  • Conquest Research - Winter Park /ID# 277760, Winter Park · Miili 5 fagaatti
  • K2 Medical Research - Clermont /ID# 277859, Clermont · Miili 24 fagaatti
Umuriin 50 hanga 90 · Saalaa hunda · Haaromfame 18-Ful-2026 · NCT07599670

A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease (ADAGIO-1)

Namoota walitti qabaa jiraSadarkaa 3
  • Combined Research Orlando (CRO), Orlando
  • Local Institution - 1622, Maitland · Miili 6 fagaatti
  • Local Institution - 1631, Maitland · Miili 6 fagaatti
Umuriin 55 hanga 90 · Saalaa hunda · Haaromfame 16-Ful-2026 · NCT07011732

A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease

Namoota walitti qabaa jiraSadarkaa 3
  • Local Institution - 2634, Orlando
Umuriin 55 hanga 90 · Saalaa hunda · Haaromfame 16-Ful-2026 · NCT07011745

A Study of Trontinemab in Cognitively Unimpaired Individuals at Risk for Progression to Symptomatic Alzheimer's Disease

Namoota walitti qabaa jiraSadarkaa 3
  • K2 Medical Research, LLC, Maitland · Miili 6 fagaatti
Umuriin 55 hanga 80 · Saalaa hunda · Haaromfame 10-Ful-2026 · NCT07717411

Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986368, for the Treatment of Agitation in Participants With Alzheimer's Disease

Namoota walitti qabaa jiraSadarkaa 2
  • ClinCloud, Maitland · Miili 6 fagaatti
  • Local Institution - 0007, Maitland · Miili 6 fagaatti
Umuriin 55 hanga 90 · Saalaa hunda · Haaromfame 01-Ful-2026 · NCT06808984

A Clinical Study of MK-2214 in People With Early Alzheimer's Disease (MK-2214-004)

Namoota walitti qabaa jiraSadarkaa 2
  • Charter Research - Orlando ( Site 1051), Orlando
  • Conquest Research LLC ( Site 1053), Winter Park · Miili 5 fagaatti
  • K2 Medical Research ( Site 1047), Maitland · Miili 6 fagaatti
Umuriin 50 hanga 85 · Saalaa hunda · Haaromfame 26-Hag-2026 · NCT07033494

A First-In-Human Study of LY3954068 in Participants With Early Symptomatic Alzheimer's Disease

Namoota walitti qabaa jiraSadarkaa 1
  • K2 Medical Research, LLC, Maitland · Miili 6 fagaatti
Umuriin 50 hanga 85 · Saalaa hunda · Haaromfame 24-Hag-2026 · NCT06297590

A Study to Assess the Effects of ACI-24.060 in Alzheimer's Disease and in Down Syndrome (ABATE Study)

Namoota walitti qabaa jiraSadarkaa 1/2
  • Charter Research, LLC, Orlando
  • Headlands Horizons LLC, Orlando
Umuriin 35 hanga 85 · Saalaa hunda · Haaromfame 10-Ado-2026 · NCT05462106

Low-Dose Radiotherapy for Alzheimer's Disease

Namoota walitti qabaa jiraSadarkaa 1/2
  • Renaissance Institute of Precision Oncology & Radiosurgery, Winter Park · Miili 5 fagaatti
Umuriin 50 fi ol · Saalaa hunda · Haaromfame 09-Ado-2026 · NCT07693140

A Study of Donanemab (LY3002813) in Participants Who Completed Study AACM (TRAILBLAZER-ALZ 3-EXT).

Namoota walitti qabaa jiraSadarkaa 3
  • Charter Research - Orlando, Orlando
  • Headlands Research Orlando, Orlando
  • Conquest Research, Winter Park · Miili 5 fagaatti
  • fi 1 dabalataa
Umuriin 55 fi ol · Saalaa hunda · Haaromfame 07-Ado-2026 · NCT07602582

A Clinical Trial to Learn About the Effects of VHB937 in People With Early Alzheimer's Disease

Namoota walitti qabaa jiraSadarkaa 2
  • Conquest Research, Winter Park · Miili 5 fagaatti
  • K2 Medical Research LLC, Maitland · Miili 6 fagaatti
  • K2 Medical Research LLC, Maitland · Miili 6 fagaatti
Umuriin 50 hanga 85 · Saalaa hunda · Haaromfame 26-Wax-2026 · NCT07094516

A Study of LY4006895 in Healthy Participants With Early Symptomatic Alzheimer's Disease (AD)

Namoota walitti qabaa jiraSadarkaa 1Hojjettoota fayyaa simatamoo
  • K2 Medical Research, Maitland · Miili 6 fagaatti
Umuriin 45 hanga 85 · Saalaa hunda · Haaromfame 04-Wax-2026 · NCT06657768

[18F]PI-2620 Phase 3 Histopathological Study

Namoota walitti qabaa jiraSadarkaa 3
  • Charter Research, Winter Park · Miili 5 fagaatti
  • K2 Medical Research, Maitland · Miili 6 fagaatti
Umuriin 50 fi ol · Saalaa hunda · Haaromfame 22-Cam-2026 · NCT05641688

Development of a Database to Investigate Digital and Blood-Based Biomarkers and Their Relationship to Tau and Amyloid PET Imaging in Older Participants Who Are Cognitively Normal (CN), Have Mild Cognitive Impairment (MCI), or Have Mild-to-Moderate AD Dementia

Namoota walitti qabaa jiraQorannoo ilaalaaHojjettoota fayyaa simatamoo
  • Charter Research, Orlando
  • Conquest Research, Winter Park · Miili 5 fagaatti
  • K2 Medical Research, Maitland · Miili 6 fagaatti
  • fi 1 dabalataa
Umuriin 60 hanga 90 · Saalaa hunda · Haaromfame 15-Elb-2026 · NCT06584357

Open-label Extension Study in Participants With Early Alzheimer's Disease

Namoota walitti qabaa jiraSadarkaa 2
  • GSK Investigational Site, Maitland · Miili 6 fagaatti
Umuriin 50 hanga 85 · Saalaa hunda · Haaromfame 02-Gur-2026 · NCT07105709

ExAblate Blood-Brain Barrier (BBB) Disruption for the Treatment of Alzheimer's Disease

Namoota walitti qabaa jira
  • Advent Health, Orlando
Umuriin 50 hanga 85 · Saalaa hunda · Haaromfame 09-Ama-2026 · NCT03671889

University of Central Florida CereBank

Namoota walitti qabaa jiraQorannoo ilaalaaHojjettoota fayyaa simatamoo
  • University of Central Florida, Orlando
Umuriin 18 fi ol · Dubartoota · Haaromfame 14-Bit-2025 · NCT06876857

Qorannoo Dhukkubaa Alzheimer magaalota biroo keessatti

Qorannoo biroo Orlando keessatti

Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.